University Hospital Cologne and Medical Faculty of the University of Cologne
Multimodal Imaging Group, Department of Nuclear Medicine

Presenter of 1 Presentation

DISTINCT REGIONAL AMYLOID PATTERNS FACILITATE TAU SPREADING IN AGING AND ALZHEIMER’S DISEASE

Session Type
SYMPOSIUM
Date
Fri, 18.03.2022
Session Time
05:15 PM - 07:15 PM
Room
ONSITE PLENARY: 115-117
Lecture Time
06:40 PM - 06:55 PM

Abstract

Aims

To assess the contribution of regional amyloid load to tau spreading in a cohort of amyloid-positive (Aß+) subjects using PET data.

Methods

Data of 41 cognitively unimpaired (CU) and 31 MCI patients was retrieved from ADNI, who had undergone two 18F-AV1451 (tau) and a baseline 18F-AV45 (amyloid) PET scan. Pre-processed PET scans were z-transformed using Aß- and age-matched CU subjects (n=38) as reference group. Subsequently, tau PET z-maps were thresholded at z > 1.96 and annual tau z-score change maps were computed. To identify linked regional combinations of baseline amyloid distribution and tau spreading, baseline amyloid z-maps and annual tau change maps were submitted to a data-driven parallel ICA which yields maximally correlated component pairs of these two measures. Next, regional overlap between resulting component pairs was quantified using the dice similarity coefficient (DSC). Finally, group-specific spearman correlations were performed to test the association between baseline amyloid load and annual tau change extracted from the component pairs.

Results

The p-ICA resulted in three significant component pairs (Figure 1) with relative spatial overlap suggesting a spatial disconnect between antecedent amyloid burden and subsequent tau spreading. Greater amyloid burden was positively associated with higher annual tau change in component pairs 1 and 3 in the CU group, and in component pair 2 for the MCI group pointing towards a stage-dependent role of regional amyloid on tau spreading.figure1_adpd.png

Conclusions

Baseline amyloid distribution patterns may inform on subsequent regional increases of tau pathology, and thus the neuropathological course of Alzheimer’s disease.

Hide